Enhanced efficacy of photodynamic therapy in combination with 5% imiquimod -a randomised, prospective, observer-blinded study in patients with non melanoma skin cancer [Erhöhte Wirksamkeit der photodynamischen Therapie durch Kombination mit 5% Imiquimod?- eine randomisierte, prospektive Studie in Patienten mit nicht melanozytären Hauttumoren]

Trial Profile

Enhanced efficacy of photodynamic therapy in combination with 5% imiquimod -a randomised, prospective, observer-blinded study in patients with non melanoma skin cancer [Erhöhte Wirksamkeit der photodynamischen Therapie durch Kombination mit 5% Imiquimod?- eine randomisierte, prospektive Studie in Patienten mit nicht melanozytären Hauttumoren]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Nov 2013

At a glance

  • Drugs Imiquimod (Primary) ; Aminolevulinic acid
  • Indications Basal cell cancer; Skin cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top